Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials
Publication in refereed journal


Times Cited
Altmetrics Information
.

Other information
AbstractBackground: Acetylcholinesterase inhibitor (AChEI) and memantine are recognized drug treatments with limited clinical efficacy. Combination therapy for patients with Alzheimer disease (AD) was suggested, but the additional benefit of combination therapy is still controversial.
All Author(s) ListTsoi KKF, Chan JYC, Leung NWY, Hirai HW, Wong SYS, Kwok TCY
Journal nameJournal of the American Medical Directors Association
Year2016
Month9
Day1
Volume Number17
Issue Number9
PublisherELSEVIER SCIENCE INC
Pages863.e1 - 863.e8
ISSN1525-8610
LanguagesEnglish-United Kingdom
KeywordsAChEI; Alzheimer disease; Combination; memantine; monotherapy
Web of Science Subject CategoriesGeriatrics & Gerontology

Last updated on 2020-29-10 at 01:33